Oleoylethanolamide attenuates early skeletal muscle metabolic remodeling induced by short-term high-fat diet exposure

Marzia Friuli1, Barbara Eramo2, Nisha Zahid2

  • 1Department of Life Science, Health, and Health Professions, Link Campus University, Via del Casale di S. Pio V, Rome 00165, Italy.

Insights

Oleoylethanolamide (OEA) prevents early skeletal muscle changes caused by high-fat diets. This research shows OEA preserves muscle metabolic and structural health, offering a potential strategy against obesity development.

Area of Science:

  • Metabolic research
  • Obesity research
  • Skeletal muscle physiology

Background:

  • Obesity stems from early metabolic changes preceding overt disease.
  • Skeletal muscle is a key metabolic organ affected early by high-fat diets (HFD).
  • Oleoylethanolamide (OEA), a PPAR-α agonist, has known metabolic benefits but its effect on early HFD-induced muscle changes is unclear.

Purpose of the Study:

  • To investigate if OEA can counteract early metabolic adaptations in skeletal muscle due to HFD exposure.
  • To understand OEA's impact on skeletal muscle remodeling during the initial stages of HFD-induced metabolic dysfunction.

Main Methods:

  • Young male rats were fed an HFD for seven weeks.
  • OEA (10 mg/kg) was administered intraperitoneally during the final two weeks of HFD exposure.
  • Skeletal muscle adaptations were analyzed, focusing on lipid metabolism, mitochondrial function, redox balance, extracellular matrix, and myogenic signaling.

Main Results:

  • Short-term HFD induced skeletal muscle lipid accumulation, suppressed the PPAR-α/CPT-1 pathway, and altered mitochondrial/redox homeostasis.
  • HFD also caused extracellular matrix remodeling, impaired myogenic signaling, and shifted muscle towards glycolysis despite minimal weight gain.
  • OEA treatment largely prevented these HFD-induced alterations, improving lipid oxidation, mitochondrial function, and tissue remodeling.

Conclusions:

  • Skeletal muscle undergoes significant remodeling early in response to HFD, preceding substantial weight gain.
  • OEA effectively preserves skeletal muscle metabolic and structural integrity against early HFD-induced changes.
  • OEA shows promise as a pharmacological agent to target early metabolic dysfunction and prevent obesity development.

Related Concept Videos